Key Metrics of Organon & Co.
Revenue$6.3B▲ 1.4% YoYFY 2023
Operating income—
Net profit$1.0B▲ 11.6% YoY
Shareholders' equity−$70.0M
Market cap$3.6BOGN · $13.75
Competitors10identified
About Organon & Co.
Part of Merck & Co..
Sectors
Company details
- Website
- organon.com
- Founded
- 2021
- Listed
- NYSE: OGN (since 2021)
Operational Areas of Organon & Co.
Pharmaceuticals & Healthcare›Formulations & Contract Manufacturing
Company summary
Legal nameOrganon & Co.
TickerOGN
ExchangeNYSE
CountryUnited States
SEC CIK0001821825
Listed since2021
IndustryBiotechnology: Pharmaceutical Preparations
SectorPharmaceuticals & Healthcare · Formulations & Contract Manufacturing
Websitehttps://www.organon.com
US market & SEC filings
OGN · NYSE · SEC CIK 0001821825
Last price · 23 Oct 2026
$13.75
−0.07%
Market cap$3.6B
P/E3.4On FY 2023 diluted EPS
Volume2,555,752
SectorHealth CareBiotechnology: Pharmaceutical Preparations
Country · IPOUnited StatesListed 2021
OGN share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricingVendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered officeOss
GSTIN—
Email—
Websitehttps://www.organon.com
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Competitors of Organon & Co.
Competitors10identified
Countries1most in United States
Top competitors by location
| Company | Description | Domain | Founded | Location |
|---|---|---|---|---|
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | lilly.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | jjmt.com.tw | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | merck.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pg.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | amgen.com | 1983 | United States | |
| Part of Gilead Sciences. | gilead.com | 1992 | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | abbott.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pfizer.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | bms.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | marriott.com.cn | — | United States |
Similar companies
B
Brooks Laboratories LimitedPharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing
M
Morepen Laboratories LimitedPharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing
N
Nectar Lifesciences LimitedPharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing
T
Themis Medicare LimitedPharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing
S
Sakar Healthcare LimitedPharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing
I
IOL Chemicals and Pharmaceuticals Ltd. (India)Pharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing
P
Poly Medicure (India)Pharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing
S
Suven Life Sciences (India)Pharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Group companies
Part of Merck & Co.
Business activities and related parties
pharmaceutical industry
Filings
No filings on record yet.